111 related articles for article (PubMed ID: 22552216)
1. Prospective evaluation of molecular markers for the staging and prognosis of upper tract urothelial carcinoma.
Bagrodia A; Youssef RF; Kapur P; Darwish OM; Cannon C; Belsante MJ; Gerecci D; Sagalowsky AI; Shariat SF; Lotan Y; Margulis V
Eur Urol; 2012 Jul; 62(1):e27-9. PubMed ID: 22552216
[No Abstract] [Full Text] [Related]
2. Histologic variants of upper tract urothelial carcinoma do not affect response to adjuvant chemotherapy after radical nephroureterectomy.
Xylinas E; Rink M; Margulis V; Karakiewicz PI; Bensalah K; Shariat SF;
Eur Urol; 2012 Jul; 62(1):e25-6. PubMed ID: 22537797
[No Abstract] [Full Text] [Related]
3. Radical nephroureterectomy for pathologic T4 upper tract urothelial cancer: can oncologic outcomes be improved with multimodality therapy?
Youssef RF; Lotan Y; Sagalowsky AI; Shariat SF; Wood CG; Raman JD; Langner C; Zigeuner R; Roscigno M; Montorsi F; Bolenz C; Kassouf W; Margulis V
Int Braz J Urol; 2013; 39(5):614-21. PubMed ID: 24267122
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors in upper urinary tract urothelial carcinomas: a comprehensive review of the current literature.
Lughezzani G; Burger M; Margulis V; Matin SF; Novara G; Roupret M; Shariat SF; Wood CG; Zigeuner R
Eur Urol; 2012 Jul; 62(1):100-14. PubMed ID: 22381168
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors for upper urinary tract urothelial carcinoma after nephroureterectomy.
Kuroda K; Asakuma J; Horiguchi A; Tasaki S; Yoshii H; Sato A; Ito K; Seguchi K; Sumitomo M; Asano T
Urol Int; 2012; 88(2):225-31. PubMed ID: 22236640
[TBL] [Abstract][Full Text] [Related]
6. Antegrade perfusion with bacillus Calmette-Guérin in patients with non-muscle-invasive urothelial carcinoma of the upper urinary tract: who may benefit?
Giannarini G; Kessler TM; Birkhäuser FD; Thalmann GN; Studer UE
Eur Urol; 2011 Nov; 60(5):955-60. PubMed ID: 21807456
[TBL] [Abstract][Full Text] [Related]
7. Comorbidity status does not independently predict survival outcomes after radical nephroureterectomy for upper tract urothelial carcinoma.
Fairey AS; Jacobsen NE; Estey E; Tanguay S; Rendon R; Bell D; Izawa J; Chin J; Kapoor A; Matsumoto E; Black P; So A; Lattouf JB; Saad F; Drachenberg D; Cagiannos I; Lacombe L; Fradet Y; Kassouf W
Eur Urol; 2013 Sep; 64(3):518-9. PubMed ID: 23796500
[No Abstract] [Full Text] [Related]
8. Predicting clinical outcomes after radical nephroureterectomy for upper tract urothelial carcinoma.
Cha EK; Shariat SF; Kormaksson M; Novara G; Chromecki TF; Scherr DS; Lotan Y; Raman JD; Kassouf W; Zigeuner R; Remzi M; Bensalah K; Weizer A; Kikuchi E; Bolenz C; Roscigno M; Koppie TM; Ng CK; Fritsche HM; Matsumoto K; Walton TJ; Ehdaie B; Tritschler S; Fajkovic H; Martínez-Salamanca JI; Pycha A; Langner C; Ficarra V; Patard JJ; Montorsi F; Wood CG; Karakiewicz PI; Margulis V
Eur Urol; 2012 Apr; 61(4):818-25. PubMed ID: 22284969
[TBL] [Abstract][Full Text] [Related]
9. Impact of tumor location on prognosis for patients with upper tract urothelial carcinoma managed by radical nephroureterectomy.
Raman JD; Ng CK; Scherr DS; Margulis V; Lotan Y; Bensalah K; Patard JJ; Kikuchi E; Montorsi F; Zigeuner R; Weizer A; Bolenz C; Koppie TM; Isbarn H; Jeldres C; Kabbani W; Remzi M; Waldert M; Wood CG; Roscigno M; Oya M; Langner C; Wolf JS; Ströbel P; Fernández M; Karakiewcz P; Shariat SF
Eur Urol; 2010 Jun; 57(6):1072-9. PubMed ID: 19619934
[TBL] [Abstract][Full Text] [Related]
10. Prognostic impact of p63 and p53 expression in upper urinary tract transitional cell carcinoma.
Zigeuner R; Tsybrovskyy O; Ratschek M; Rehak P; Lipsky K; Langner C
Urology; 2004 Jun; 63(6):1079-83. PubMed ID: 15183954
[TBL] [Abstract][Full Text] [Related]
11. Laparoscopic nephroureterectomy for upper tract transitional cell carcinoma: comparison of laparoscopic and open surgery.
Tsujihata M; Nonomura N; Tsujimura A; Yoshimura K; Miyagawa Y; Okuyama A
Eur Urol; 2006 Feb; 49(2):332-6. PubMed ID: 16387415
[TBL] [Abstract][Full Text] [Related]
12. Outcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma Collaboration.
Margulis V; Shariat SF; Matin SF; Kamat AM; Zigeuner R; Kikuchi E; Lotan Y; Weizer A; Raman JD; Wood CG;
Cancer; 2009 Mar; 115(6):1224-33. PubMed ID: 19156917
[TBL] [Abstract][Full Text] [Related]
13. Lymphangiogenesis occurs in upper tract urothelial carcinoma and correlates with lymphatic tumour dissemination and poor prognosis.
Bolenz C; Fernández MI; Trojan L; Hoffmann K; Herrmann E; Steidler A; Weiss C; Ströbel P; Alken P; Michel MS
BJU Int; 2009 Apr; 103(8):1040-6. PubMed ID: 18990139
[TBL] [Abstract][Full Text] [Related]
14. Renal safety and efficacy of cisplatin-based chemotherapy in patients with a solitary kidney after nephroureterectomy for urothelial carcinoma of the upper urinary tract.
Cho KS; Joung JY; Seo HK; Cho IC; Chung HS; Chung J; Lee KH
Cancer Chemother Pharmacol; 2011 Apr; 67(4):769-74. PubMed ID: 20532510
[TBL] [Abstract][Full Text] [Related]
15. Retroperitoneal lymph node dissection (RPLD) in conjunction with nephroureterectomy in the treatment of infiltrative transitional cell carcinoma (TCC) of the upper urinary tract: impact on survival.
Brausi MA; Gavioli M; De Luca G; Verrini G; Peracchia G; Simonini G; Viola M
Eur Urol; 2007 Nov; 52(5):1414-8. PubMed ID: 17507148
[TBL] [Abstract][Full Text] [Related]
16. Prospective trial of ifosfamide, paclitaxel, and cisplatin in patients with advanced non-transitional cell carcinoma of the urothelial tract.
Galsky MD; Iasonos A; Mironov S; Scattergood J; Donat SM; Bochner BH; Herr HW; Russo P; Boyle MG; Bajorin DF
Urology; 2007 Feb; 69(2):255-9. PubMed ID: 17320659
[TBL] [Abstract][Full Text] [Related]
17. Laparoscopic radical nephroureterectomy for upper tract transitional cell carcinoma: oncological outcomes at 7 years.
Berger A; Haber GP; Kamoi K; Aron M; Desai MM; Kaouk JH; Gill IS
J Urol; 2008 Sep; 180(3):849-54; discussion 854. PubMed ID: 18635229
[TBL] [Abstract][Full Text] [Related]
18. Role of chemotherapy in upper urinary tract urothelial cell cancers.
Kwan A; Mazhar D
Future Oncol; 2011 Sep; 7(9):1067-75. PubMed ID: 21919694
[TBL] [Abstract][Full Text] [Related]
19. Prospective evaluation of the prognostic relevance of molecular staging for urothelial carcinoma.
Copp HL; Chin JL; Conaway M; Theodorescu D
Cancer; 2006 Jul; 107(1):60-6. PubMed ID: 16691580
[TBL] [Abstract][Full Text] [Related]
20. Glucose-regulated protein 78 expression in urothelial carcinoma of the upper urinary tract.
Uematsu K; Ogata S; Nakanishi K; Hiroi S; Tominaga S; Aida S; Kawai T
BJU Int; 2010 Sep; 106(6):873-8. PubMed ID: 20039870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]